Back

PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Plaque characterisation and disease progression on cardiac computed tomography angiography Plaque Imaging ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marios Sagris

Hippokration General Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Plaque composition in symptomatic versus asymptomatic women and men: data from the CONFIRM2 registry
Doctor S. Cramer (Amsterdam, NL)
Abstract
Presentation thumbnail
Polygenic risk score as a predictor of coronary artery disease severity and plaque features in CCTA
Doctor S. Mushtaq (Milan, IT)
Abstract
Presentation thumbnail
High Lipoprotein(a) levels and coronary plaque burden: 175 nmol/L as a potential target for early CT-based risk assessment
Associate Professor P. Breitbart (Frankfurt am Main, DE)
Abstract
Presentation thumbnail
Effects of statin treatment on coronary plaque morphology: longitudinal radiomics-based precision phenotyping using coronary computed tomography angiography
Mr J. Stewart (Melbourne, AU)
Abstract

Access the full session

Session thumbnail
Plaque characterisation and disease progression on cardiac computed tomography angiography

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis
1 September 2025
thumbnail
Congress Presentation
Identification of different lipid profiles in patients with zero calcium score with or without plaques after coronary computed tomography: a prospective registry to refine primary prevention
30 August 2025
thumbnail
Congress Presentation
Incremental prognostic value of artificial intelligence-based automated plaque characterisation on top of ischemia evaluation by CCTA and CCTA/PET
20 May 2024
thumbnail
Congress Presentation
Time course of LDL-C lowering after initiation of PCSK9 inhibition or bempedoic acid in atherosclerotic cardiovascular disease
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources